Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Glass Pharms Welcomes Adam George as New Chairman

by
January 8, 2025
in Economy, Investing
0
Glass Pharms Welcomes Adam George as New Chairman
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Glass Pharms, a leading UK-based medical cannabis cultivation company, is pleased to announce the appointment of Adam George as Chairman, effective as of December 1st, 2024.

Adam brings with him over 13 years of experience in the pharmaceutical cannabis industry, having previously held positions such as CFO and UK managing director at GW Pharmaceuticals. His extensive knowledge and expertise in this field will be instrumental in supporting Glass Pharms’ mission to provide high quality pharmaceutical cannabis products to patients in the UK.

James Duckenfield, Glass Pharms’ chief executive, expressed his enthusiasm for the new addition to the board, stating, “We are delighted that Adam has joined the team. His experience and expertise will be invaluable as we continue to strive towards our goal of providing reliable and high-quality cannabis-based medicines to patients in the UK.”

Adam George left GW Pharmaceuticals, now known as Jazz Pharmaceuticals, in 2020 and has since been involved in various businesses focused on developing medicines derived from natural sources, including plants and fungi.

In his statement, Adam said, “I am thrilled to be joining Glass Pharms at such an exciting time. With a world-class cultivation facility and a dedicated team, the company is well-positioned to meet the increasing demand for high-quality, UK-produced cannabis-based medicines.”

Glass Pharms is a licensed cultivator of cannabis, exclusively for the medical supply chain, in the UK. The company was founded with the aim of providing patients with a dependable supply of high-quality, UK-produced cannabis-based medicines at an affordable price. With a talented growing team and a unique patent-pending continuous cultivation system, Glass Pharms is able to produce a consistent supply of pharmaceutical-grade cannabis. This innovative system uses automation and climate chambers to simulate a full growing year in just 12 weeks, using only 40% of the power required by traditional indoor growing facilities. Additionally, the company is committed to using off-grid green energy to power its operations.

For more information about Glass Pharms, please visit their website at https://glasspharms.com/. For media inquiries, please contact Mark Heley at info@glasspharms.com.

This news release was distributed by https://pressat.co.uk/.

ShareTweetPin

Related Posts

Top 5 Canadian Mining Stocks This Week: StrategX Jumps 64 Percent on Fundraising
Investing

Top 5 Canadian Mining Stocks This Week: StrategX Jumps 64 Percent on Fundraising

August 24, 2025
Tech 5: Softbank to Invest US$2 Billion in Intel, Figure Seeks Nasdaq IPO
Investing

Tech 5: Softbank to Invest US$2 Billion in Intel, Figure Seeks Nasdaq IPO

August 24, 2025
Gold Price Rises as Powell Boosts Rate Cut Expectations in Jackson Hole Speech
Investing

Gold Price Rises as Powell Boosts Rate Cut Expectations in Jackson Hole Speech

August 23, 2025
Crypto Market Update: World Liberty Gets Coinbase Approval with Stablecoin Listing
Investing

Crypto Market Update: World Liberty Gets Coinbase Approval with Stablecoin Listing

August 23, 2025
Top 5 Copper Reserves by Country
Investing

Top 5 Copper Reserves by Country

August 22, 2025
CG1 Non-renounceable Pro-rata Entitlement Offer
Investing

CG1 Non-renounceable Pro-rata Entitlement Offer

August 22, 2025
Next Post
British Study Shows Call for Clearer, More Transparent and Standardized Food Labels

British Study Shows Call for Clearer, More Transparent and Standardized Food Labels

Recommended

TMP eyes 1,800 next-gen Tamaraw sales monthly

TMP eyes 1,800 next-gen Tamaraw sales monthly

November 28, 2024
DB scheme running costs surge 37% on average in the past year

DB scheme running costs surge 37% on average in the past year

October 13, 2024
“Builders Across the UK Can Now Benefit from HazardCo’s Guided Health & Safety System”

“Builders Across the UK Can Now Benefit from HazardCo’s Guided Health & Safety System”

October 9, 2024
Alternergy lends P4.45 billion to wind subsidiary

Alternergy lends P4.45 billion to wind subsidiary

November 6, 2024
Localis Reacts to Budget 2024

Localis Reacts to Budget 2024

October 30, 2024
Ex-Tukuran officials cleared of graft

Ex-Tukuran officials cleared of graft

August 14, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved